Results 301 to 310 of about 1,580,994 (358)
Some of the next articles are maybe not open access.
Current Radiopharmaceuticalse, 2012
Radiopharmaceuticals are able to give functional information about systems, organs or cells. This functional information can be about different cell mechanisms or molecular pathways. In terms of systems or organs this information can be assessed through biodistribution studies while that in terms of cells can be evaluated through more detailed research,
Ana M. Abrantes, Maria Filomena Botelho
openaire +3 more sources
Radiopharmaceuticals are able to give functional information about systems, organs or cells. This functional information can be about different cell mechanisms or molecular pathways. In terms of systems or organs this information can be assessed through biodistribution studies while that in terms of cells can be evaluated through more detailed research,
Ana M. Abrantes, Maria Filomena Botelho
openaire +3 more sources
Clinical Breast Cancer, 2003
The world of breast cancer research has always, to some extent, been a global enterprise but never so much as it is today. Wherever one looks, there is evidence that breast cancer research is undergoing the same globalization that characterizes so much of industry and culture.
openaire +3 more sources
The world of breast cancer research has always, to some extent, been a global enterprise but never so much as it is today. Wherever one looks, there is evidence that breast cancer research is undergoing the same globalization that characterizes so much of industry and culture.
openaire +3 more sources
The emerging role of photoacoustic imaging in clinical oncology
Nature Reviews Clinical Oncology, 2022Li Lin, Lihong V. Wang
semanticscholar +1 more source
Toxicity and response criteria of the Eastern Cooperative Oncology Group
American Journal of Clinical Oncology, 1982M. Oken +6 more
semanticscholar +1 more source
Delivering precision oncology to patients with cancer
Nature Network Boston, 2022J. Mateo +14 more
semanticscholar +1 more source
2014
Over the past decade, the efficacy of modern chemotherapy, with or without targeted therapy, has been markedly improved. Systemic therapy generates substantial tumour regression in around 50 % of patients with metastatic colorectal cancer, median progression-free survival is prolonged to around 9 months, median overall survival approaches 2 years and ...
openaire +3 more sources
Over the past decade, the efficacy of modern chemotherapy, with or without targeted therapy, has been markedly improved. Systemic therapy generates substantial tumour regression in around 50 % of patients with metastatic colorectal cancer, median progression-free survival is prolonged to around 9 months, median overall survival approaches 2 years and ...
openaire +3 more sources